Pharmaceutical manufacturing remains one of the world?s most profitable industries but is under increasing price and margin
pressure from ever more cost conscious Governments and customers. An anticipated loss of approximately $78 billion in 2009
- 2014 resulting from patent cliffs, shrinking profit margins and increasingly heavy competition, growing regulatory pressure due
to highly publicized drug dangers, recurring threats of litigation over real or perceived drug side effects, shifting demographic
trends in both western and emerging markets, driving the demand for more and better pharmaceuticals and growing threats to
intellectual property. These are the challenges the global pharmaceutical industry is facing today. To address these issues and
minimize their negative impact to the extent possible, pharmaceutical firms are proactively and significantly changing their
business models. One important strategic response to this has been to outsource, they are increasingly leveraging outsourcing
to enable focused excellence on the core business of pharmaceuticals while abating the above issues. This article focuses on the
outsourcing strategies of pharmaceutical manufacturers are evolving in today?s dynamic and challenging environment. In the
course of research, companies use outsourcing partnerships to overcome challenges and achieve competitive advantage.
I am Anand Manne currently in Ist M. Pharm- Pharmaceutical Regulatory Affairs in jss college of pharmacy, mysore. I have completed my bachelors
in pharmacy from Manipal College of Pharmaceutical Sciences and have attended and volunteered for various conferences and seminars.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals